• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[MAS-like lesions and SIADH caused by bortezomib in the treatment of multiple myeloma : three cases report and literature review].

作者信息

Wang L L, Geng C Y, Zhang Y R, Wu Y

机构信息

Department of Hematology, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2022 Jan 14;43(1):75-77. doi: 10.3760/cma.j.issn.0253-2727.2022.01.015.

DOI:10.3760/cma.j.issn.0253-2727.2022.01.015
PMID:35231998
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8980669/
Abstract
摘要

相似文献

1
[MAS-like lesions and SIADH caused by bortezomib in the treatment of multiple myeloma : three cases report and literature review].[硼替佐米治疗多发性骨髓瘤所致类巨噬细胞活化综合征样病变和抗利尿激素分泌异常综合征：三例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2022 Jan 14;43(1):75-77. doi: 10.3760/cma.j.issn.0253-2727.2022.01.015.
2
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) due to bortezomib in a case of light chain multiple mieloma. Treatment with tolvaptan.硼替佐米引起的抗利尿激素分泌不当综合征（SIADH）在一例轻链多发性骨髓瘤患者中的情况。使用托伐普坦进行治疗。
Nefrologia. 2017 Sep-Oct;37(5):558-559. doi: 10.1016/j.nefro.2016.10.015.
3
Bortezomib-induced syndrome of inappropriate antidiuresis in a patient with multiple myeloma: A case report and literature review
.硼替佐米诱发的多发性骨髓瘤患者抗利尿激素分泌失调综合征：一例报告及文献综述
Int J Clin Pharmacol Ther. 2017 Dec;55(12):910-914. doi: 10.5414/CP203109.
4
Real world experience of bortezomib re-treatment for patients with multiple myeloma at first relapse.硼替佐米对首次复发的多发性骨髓瘤患者进行再治疗的真实世界经验。
Br J Haematol. 2017 May;177(3):495-497. doi: 10.1111/bjh.14086. Epub 2016 Apr 8.
5
[Syndrome of inappropriate secretion of antidiuretic hormone in multiple myeloma patients treated with bortezomib, lenalidomide, and dexamethasone combination therapy].硼替佐米、来那度胺和地塞米松联合治疗的多发性骨髓瘤患者抗利尿激素分泌异常综合征
Rinsho Ketsueki. 2018;59(11):2423-2427. doi: 10.11406/rinketsu.59.2423.
6
Bortezomib-Associated Optic Atrophy in Two Patients With Multiple Myeloma.硼替佐米引起的两名多发性骨髓瘤患者视神经萎缩
J Neuroophthalmol. 2018 Dec;38(4):473-475. doi: 10.1097/WNO.0000000000000657.
7
Sensorineural deafness: An uncommon irreversible adverse effect of bortezomib.感音神经性耳聋：硼替佐米一种罕见的不可逆不良反应。
Indian J Cancer. 2016 Jul-Sep;53(3):459. doi: 10.4103/0019-509X.200675.
8
Corneal sub-basal neural damage pattern in multiple myeloma patients treated with bortezomib: an in vivo confocal study.
Leuk Lymphoma. 2015;56(12):3440-1. doi: 10.3109/10428194.2015.1023723. Epub 2015 Jun 18.
9
Cardiotoxicity risk with bortezomib versus lenalidomide for treatment of multiple myeloma: A propensity matched study of 1,790 patients.
Am J Hematol. 2017 Feb;92(2):E15-E17. doi: 10.1002/ajh.24599.
10
Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis.硼替佐米治疗多发性骨髓瘤和轻链淀粉样变性后巨细胞病毒再激活。
Eur J Haematol. 2020 Mar;104(3):230-235. doi: 10.1111/ejh.13366. Epub 2020 Jan 10.

本文引用的文献

1
[Chinese guidelines for the diagnosis and treatment of heart failure 2018].《中国心力衰竭诊断和治疗指南2018》
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Oct 24;46(10):760-789. doi: 10.3760/cma.j.issn.0253-3758.2018.10.004.
2
Prognostic Factors of Death in 151 Adults With Hemophagocytic Syndrome: Etiopathogenically Driven Analysis.151例成人噬血细胞综合征患者死亡的预后因素：病因驱动分析
Mayo Clin Proc Innov Qual Outcomes. 2018 Aug 1;2(3):267-276. doi: 10.1016/j.mayocpiqo.2018.06.006. eCollection 2018 Sep.
3
Inflammasome activation by cell volume regulation and inflammation-associated hyponatremia: A vicious cycle.通过细胞容积调节和炎症相关低钠血症激活炎性小体：一个恶性循环。
Med Hypotheses. 2016 Aug;93:117-21. doi: 10.1016/j.mehy.2016.05.018. Epub 2016 May 18.
4
[Mechanism of action and determinants of sensitivity to the proteasome inhibitor bortezomib in multiple myeloma therapy].[蛋白酶体抑制剂硼替佐米在多发性骨髓瘤治疗中的作用机制及敏感性决定因素]
Rinsho Ketsueki. 2016 May;57(5):537-45. doi: 10.11406/rinketsu.57.537.
5
Hyponatremia in patients with systemic lupus erythematosus.系统性红斑狼疮患者的低钠血症
Sci Rep. 2016 May 19;6:25566. doi: 10.1038/srep25566.
6
Tolvaptan in hospitalized cancer patients with hyponatremia: a double-blind, randomized, placebo-controlled clinical trial on efficacy and safety.托伐普坦治疗住院癌症伴低钠血症患者的疗效和安全性：一项双盲、随机、安慰剂对照临床试验。
Cancer. 2014 Mar 1;120(5):744-51. doi: 10.1002/cncr.28468. Epub 2013 Nov 5.
7
Inflammation and hyponatremia: an underrecognized condition?炎症与低钠血症：一种未被充分认识的病症？
Korean J Pediatr. 2013 Dec;56(12):519-22. doi: 10.3345/kjp.2013.56.12.519. Epub 2013 Dec 20.
8
Hyponatremia may reflect severe inflammation in children with febrile urinary tract infection.低钠血症可能反映出患有发热性尿路感染的儿童的严重炎症。
Pediatr Nephrol. 2012 Dec;27(12):2261-7. doi: 10.1007/s00467-012-2267-9. Epub 2012 Jul 31.
9
Changes in renal sodium transport during a systemic inflammatory response.全身炎症反应期间肾钠转运的变化。
Pediatr Nephrol. 2006 Oct;21(10):1487-8; author reply 1489. doi: 10.1007/s00467-006-0199-y. Epub 2006 Aug 1.
10
Incidence and prevalence of hyponatremia.低钠血症的发病率和患病率。
Am J Med. 2006 Jul;119(7 Suppl 1):S30-5. doi: 10.1016/j.amjmed.2006.05.005.